Tenascin-C: an emerging prognostic biomarker in diabetes.
作者信息
Yonebayashi Saori, Tajiri Kazuko, Li Siqi, Sato Akira
机构信息
Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
出版信息
Ann Transl Med. 2020 Dec;8(24):1699. doi: 10.21037/atm-2020-116.
Abstract
摘要
相似文献
1
Tenascin-C: an emerging prognostic biomarker in diabetes.腱生蛋白-C：糖尿病中一种新兴的预后生物标志物。
Ann Transl Med. 2020 Dec;8(24):1699. doi: 10.21037/atm-2020-116.
2
3
Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.腱生蛋白-C血清水平及其在非小细胞肺癌中的预后价值
Oncotarget. 2016 Apr 12;7(15):20945-52. doi: 10.18632/oncotarget.7976.
4
Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy.血清 tenascin-C 水平作为肥厚型心肌病心力衰竭事件的预后生物标志物。
J Cardiol. 2012 Mar;59(2):209-14. doi: 10.1016/j.jjcc.2011.11.008. Epub 2012 Jan 2.
5
Correlation of tenascin-C concentrations in serum with outcome of traumatic brain injury in humans.血清中 tenascin-C 浓度与人类创伤性脑损伤结果的相关性。
Clin Chim Acta. 2017 Sep;472:46-50. doi: 10.1016/j.cca.2017.07.018. Epub 2017 Jul 18.
6
Prognostic Role of Tenascin-C for Cancer Outcome: A Meta-Analysis.Tenascin-C 对癌症结局的预后作用：一项荟萃分析。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033818821106. doi: 10.1177/1533033818821106.
7
Tenascin-C expression and its prognostic significance in colorectal cancer.结直肠癌中肌腱蛋白-C的表达及其预后意义
Oncology. 2007;72(5-6):403-9. doi: 10.1159/000113490. Epub 2008 Jan 15.
8
Serum tenascin-C predicts severity and outcome of acute intracerebral hemorrhage.血清 tenascin-C 可预测急性脑出血的严重程度和转归。
Clin Chim Acta. 2018 Jun;481:69-74. doi: 10.1016/j.cca.2018.02.033. Epub 2018 Feb 27.
9
Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.腱生蛋白-C，食管鳞状细胞癌的一个预后决定因素。
PLoS One. 2016 Jan 5;11(1):e0145807. doi: 10.1371/journal.pone.0145807. eCollection 2016.
10
Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.结直肠癌基质中的肌腱蛋白C是肝转移的预测标志物，并且是通过微小RNA分析确定的miR-198的有效靶点。
Br J Cancer. 2017 Oct 24;117(9):1360-1370. doi: 10.1038/bjc.2017.291. Epub 2017 Aug 24.
引用本文的文献
1
Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy.肌腱蛋白-C在糖尿病性心肌病小鼠模型中引发心血管功能障碍。
Cardiovasc Diabetol. 2025 May 31;24(1):235. doi: 10.1186/s12933-025-02780-y.
2
Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT.骨桥蛋白缺失通过改善胰岛β细胞功能障碍和减少肾脏 EMT 来减轻糖尿病肾病中的肾纤维化。
Sci Rep. 2023 Oct 16;13(1):17599. doi: 10.1038/s41598-023-44177-5.
3
Tenascin-C in fibrosis in multiple organs: Translational implications.细胞外基质蛋白 tenascin-C 在多器官纤维化中的作用：转化医学意义。
Semin Cell Dev Biol. 2022 Aug;128:130-136. doi: 10.1016/j.semcdb.2022.03.019. Epub 2022 Apr 8.
4
Multiparametric Evaluation of Post-MI Small Animal Models Using Metabolic ([F]FDG) and Perfusion-Based (SYN1) Heart Viability Tracers.采用代谢 ([F]FDG) 和灌注 (SYN1) 心脏存活示踪剂对心肌梗死后小动物模型进行多参数评估。
Int J Mol Sci. 2021 Nov 22;22(22):12591. doi: 10.3390/ijms222212591.
本文引用的文献
1
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort.血清 tenascin-C 与 2 型糖尿病患者主要不良心血管事件和死亡的增加独立相关：一项法国前瞻性队列研究。
Diabetologia. 2020 May;63(5):915-923. doi: 10.1007/s00125-020-05108-5. Epub 2020 Feb 10.
2
Tenascin-C accelerates adverse ventricular remodelling after myocardial infarction by modulating macrophage polarization.Tenascin-C 通过调节巨噬细胞极化加速心肌梗死后的不良心室重构。
Cardiovasc Res. 2019 Mar 1;115(3):614-624. doi: 10.1093/cvr/cvy244.
3
Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.内政部：Tenascin-C 作为一种临床相关的内源性固有免疫驱动因素。
J Histochem Cytochem. 2018 Apr;66(4):289-304. doi: 10.1369/0022155418757443. Epub 2018 Jan 31.
4
Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.Tenascin-C 促进慢性压力超负荷诱导的心脏功能障碍、肥大和心肌纤维化。
J Hypertens. 2018 Apr;36(4):847-856. doi: 10.1097/HJH.0000000000001628.
5
Local production of tenascin-C acts as a trigger for monocyte/macrophage recruitment that provokes cardiac dysfunction.局部组织纤连蛋白 C 的产生可作为触发单核细胞/巨噬细胞募集的一个诱因，进而导致心脏功能障碍。
Cardiovasc Res. 2018 Jan 1;114(1):123-137. doi: 10.1093/cvr/cvx221.
6
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家发病率、患病率以及 195 个国家和地区 1990 年至 2016 年 328 种疾病和伤害导致的残疾年数：2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
7
Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy.心肌腱糖蛋白-C表达在扩张型心肌病患者左心室重构及长期预后中的意义
Eur J Heart Fail. 2016 Apr;18(4):375-85. doi: 10.1002/ejhf.464. Epub 2016 Jan 13.
8
Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin αVβ3/nuclear factor-κB/interleukin-6 axis.肌腱蛋白-C可能通过整联蛋白αVβ3/核因子-κB/白细胞介素-6轴激活巨噬细胞，从而加速心脏纤维化。
Hypertension. 2015 Oct;66(4):757-66. doi: 10.1161/HYPERTENSIONAHA.115.06004. Epub 2015 Aug 3.
9
Impact of serum tenascin-C on the aortic healing process during the chronic stage of type B acute aortic dissection.血清腱生蛋白-C对B型急性主动脉夹层慢性期主动脉愈合过程的影响
Int J Cardiol. 2015 Jul 15;191:97-9. doi: 10.1016/j.ijcard.2015.05.009. Epub 2015 May 6.
10
Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation.腱生蛋白-C通过树突状细胞激活和Th17细胞分化加重自身免疫性心肌炎。
J Am Heart Assoc. 2014 Nov 5;3(6):e001052. doi: 10.1161/JAHA.114.001052.
Zotero 插件